Bernhard J Steinhoff Selected Research

perampanel

4/2022	PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.
1/2021	Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review.
8/2020	Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy.
1/2020	Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
4/2019	Plasma concentration and clinical effects of perampanel-The Kork experience.
2/2017	Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
1/2016	Add-on perampanel in Lance-Adams syndrome.
5/2015	The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.
7/2014	A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria.
1/2014	Efficacy of perampanel: a review of pooled data.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernhard J Steinhoff Research Topics

Disease

42	Epilepsy (Aura) 04/2022 - 05/2002
34	Seizures (Absence Seizure) 09/2022 - 12/2006
12	Partial Epilepsies (Epilepsy, Partial) 10/2021 - 05/2002
5	Dizziness (Lightheadedness) 01/2020 - 08/2007
5	Epileptic Syndromes 01/2019 - 12/2005
3	Sleepiness 01/2020 - 08/2007
3	Cognitive Dysfunction 01/2019 - 06/2010
3	Hippocampal Sclerosis 10/2017 - 03/2013
3	Drug Resistant Epilepsy 02/2017 - 10/2005
3	Temporal Lobe Epilepsy 10/2013 - 04/2008
2	Drug Hypersensitivity Syndrome 02/2021 - 01/2020
2	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 01/2018
2	Fatigue 01/2020 - 08/2007
2	Headache (Headaches) 01/2020 - 08/2007
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018 - 12/2017
2	Syncope (Fainting) 01/2016 - 06/2011
1	Eosinophilia 02/2021
1	Idiopathic Generalized Epilepsy 08/2020
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 03/2018
1	Angiomyolipoma 01/2018
1	Hyponatremia 01/2018
1	Generalized Epilepsy 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Focal Cortical Dysplasia 10/2017
1	Bradycardia 01/2016
1	Atrioventricular Block 01/2016
1	Reflex Epilepsy (Photosensitive Epilepsy) 06/2015
1	Febrile Seizures (Febrile Seizure) 10/2013
1	Wounds and Injuries (Trauma) 06/2011
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 03/2011
1	Paresis (Hemiparesis) 09/2009
1	Pain (Aches) 06/2007
1	Body Weight (Weight, Body) 12/2006
1	Weight Loss (Weight Reduction) 12/2006
1	Malformations of Cortical Development 11/2004
1	Scrapie 11/2002
1	Myoclonus (Nocturnal Myoclonus) 11/2002
1	Acquired CJD 11/2002

Drug/Important Bio-Agent (IBA)

26	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 09/2003
14	perampanelIBA 04/2022 - 01/2013
13	Pharmaceutical PreparationsIBA 01/2022 - 08/2007
9	CenobamateIBA 09/2022 - 01/2020
6	brivaracetamIBA 01/2021 - 05/2017
5	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 10/2005
5	AMPA Receptors (AMPA Receptor)IBA 01/2016 - 08/2013
3	Topiramate (Topamax)FDA LinkGeneric 01/2021 - 12/2006
3	Lacosamide FDA Link 02/2017 - 11/2011
3	AcidsIBA 01/2016 - 08/2013
2	Sodium Channel BlockersIBA 03/2022 - 11/2011
2	trans-sodium crocetinate (crocetin)IBA 01/2021 - 01/2018
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 12/2009 - 03/2009
2	Valproic Acid (Depakote)FDA LinkGeneric 12/2006 - 12/2005
1	TabletsIBA 02/2021
1	Everolimus FDA Link 01/2021
1	Immunoglobulin E (IgE)IBA 08/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	padsevonilIBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2017
1	BenzodiazepinesIBA 12/2017
1	EnzymesIBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Anti-Arrhythmia AgentsIBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	selurampanelIBA 06/2015
1	Oxygen (Dioxygen)IBA 03/2015
1	Sodium Channels (Sodium Channel)IBA 10/2013
1	Biological ProductsIBA 10/2013
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	Delayed-Action PreparationsIBA 03/2009
1	Generic DrugsIBA 03/2007
1	Glucose (Dextrose)FDA LinkGeneric 12/2006
1	Insulin (Novolin)FDA Link 12/2006
1	Prostaglandins BIBA 11/2006
1	Pregabalin (Lyrica)FDA Link 11/2006
1	lipoarabinomannan (LAM)IBA 12/2005
1	Carbamazepine (Tegretol)FDA LinkGeneric 12/2005
1	Lamotrigine (Lamictal)FDA LinkGeneric 12/2005
1	mitomycin C-dextranIBA 11/2004
1	ParvalbuminsIBA 11/2002
1	Methionine (L-Methionine)FDA Link 11/2002
1	Codon (Codons)IBA 11/2002
1	Prion ProteinsIBA 11/2002

Therapy/Procedure

14	Therapeutics 09/2022 - 10/2005
3	Deep Brain Stimulation 01/2020 - 03/2011
2	Operative Surgical Procedures 01/2019 - 03/2015
1	Length of Stay 12/2020
1	Hemispherectomy 09/2009
1	Cognitive Training 04/2008
1	Conservative Treatment 06/2007
1	Electrodes (Electrode) 05/2002